Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1998;7(4):261–267. doi: 10.1080/09629359890947

Pharmacological evidence supporting a role for IL-1, IL-2 and serotonin in the inflammation induced by Schistosoma mansoni Soluble Egg Antigen (SEA) in rat paws.

C M Pacheco 1, C A Tavares 1, P M Coelho 1, O A Rocha 1, J M Santos 1, F R Prado 1, J N Francischi 1
PMCID: PMC1781856  PMID: 9792336

Abstract

THIS study intended to characterize pharmacologically the mediator(s) released in the inflammation induced by Soluble Egg Antigen (SEA), the main antigen released from eggs of Schistosoma mansoni, in rat hindpaws. A single intraplantar injection of 0.1-100 microg SEA at day zero induced a dose-dependent increase in the volume of rat hindpaws characterizing an oedema of quick onset (within 15 min) and 4h-duration, which was confirmed by histopathological analysis of the paws. A second injection of SEA in the same paw (1-10 microg) 28 days later induced an increased dose-dependent oedematogenic response. The early oedematogenic response following SEA sensitization was derived from serotonin release and interleukin-1 (IL-1), since treatment with either pizotifen or an antibody against IL-1, reduced the response by 60% and 48%, respectively. The increased oedematogenic response derived from SEA-challenge (10 microg) of rat paws derived from a local rather than systemic reaction, since it was not observed if the sensitization was in the contralateral paw or the peritoneal cavity of the animals. Chronic treatment with inhibitors of IL-2 synthesis/release such as cyclosporin or dexamethasone during the sensitization phase reduced the oedematogenic response due to SEA challenge by 51% and 55%, respectively. These data suggested that SEA-challenge was immune-derived and dependent of IL-2 release. It is discussed the association between cytokine release and the resistance of rats to S. mansoni infection.

Full Text

The Full Text of this article is available as a PDF (222.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed S. F., Oswald I. P., Caspar P., Hieny S., Keefer L., Sher A., James S. L. Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni. Infect Immun. 1997 Jan;65(1):219–226. doi: 10.1128/iai.65.1.219-226.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bogers J. J., Nibbeling H. A., Deelder A. M., van Marck E. A. Immunohistochemical and ultrastructural localization of Schistosoma mansoni soluble egg antigens processed by the infected host. Parasitology. 1996 Jun;112(Pt 6):537–543. doi: 10.1017/s0031182000066117. [DOI] [PubMed] [Google Scholar]
  3. Boros D. L. Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev. 1989 Jul;2(3):250–269. doi: 10.1128/cmr.2.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boros D. L. Immunoregulation of granuloma formation in murine schistosomiasis mansoni. Ann N Y Acad Sci. 1986;465:313–323. doi: 10.1111/j.1749-6632.1986.tb18507.x. [DOI] [PubMed] [Google Scholar]
  5. Boros D. L., Pelley R. P., Warren K. S. Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J Immunol. 1975 May;114(5):1437–1441. [PubMed] [Google Scholar]
  6. Cheever A. W. Schistosomiasis. Infection versus disease and hypersensitivity versus immunity. Am J Pathol. 1993 Mar;142(3):699–702. [PMC free article] [PubMed] [Google Scholar]
  7. Constant S. L., Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol. 1997;15:297–322. doi: 10.1146/annurev.immunol.15.1.297. [DOI] [PubMed] [Google Scholar]
  8. Cunha F. Q., Souza G. E., Souza C. A., Cerqueira B. C., Ferreira S. H. In-vivo blockage of neutrophil migration by LPS is mimicked by a factor released from LPS-stimulated macrophages. Br J Exp Pathol. 1989 Feb;70(1):1–8. [PMC free article] [PubMed] [Google Scholar]
  9. Emonds-Alt X., Doutremepuich J. D., Heaulme M., Neliat G., Santucci V., Steinberg R., Vilain P., Bichon D., Ducoux J. P., Proietto V. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur J Pharmacol. 1993 Dec 21;250(3):403–413. doi: 10.1016/0014-2999(93)90027-f. [DOI] [PubMed] [Google Scholar]
  10. Faulds D., Goa K. L., Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs. 1993 Jun;45(6):953–1040. doi: 10.2165/00003495-199345060-00007. [DOI] [PubMed] [Google Scholar]
  11. Francischi J. N., Dias M. F., Rocha O. A., de Abreu Castro M. S., Kiyomi Funayama Tatsuo M. A., Farinelli P., Pacheco C. M., Ferreira-Alves D. L., Sirois P. Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor. Int Arch Allergy Immunol. 1996 Apr;109(4):398–406. doi: 10.1159/000237269. [DOI] [PubMed] [Google Scholar]
  12. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R., Humphrey P. P. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev. 1994 Jun;46(2):157–203. [PubMed] [Google Scholar]
  13. James S. L., Colley D. G. A method for the isolation of Schistosoma mansoni eggs. J Parasitol. 1974 Dec;60(6):1043–1044. [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Romagnani S. The Th1/Th2 paradigm. Immunol Today. 1997 Jun;18(6):263–266. doi: 10.1016/s0167-5699(97)80019-9. [DOI] [PubMed] [Google Scholar]
  16. Wynn T. A., Jankovic D., Hieny S., Cheever A. W., Sher A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J Immunol. 1995 May 1;154(9):4701–4709. [PubMed] [Google Scholar]
  17. Wynn T. A., Oswald I. P., Eltoum I. A., Caspar P., Lowenstein C. J., Lewis F. A., James S. L., Sher A. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J Immunol. 1994 Dec 1;153(11):5200–5209. [PubMed] [Google Scholar]
  18. Wynn T. A., Reynolds A., James S., Cheever A. W., Caspar P., Hieny S., Jankovic D., Strand M., Sher A. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol. 1996 Nov 1;157(9):4068–4078. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES